The last dose of Vincristine and Daunorubicin was administered today (Fri 20th) - there were 4 in this first phase. Jeremy can look forward to 2 more Asparaginase needles in the bottom next week.
On Thursday (26th) he is booked in for his "day33" bone marrow aspirate - the result will help the doctors determine if Jeremy is High Risk, or Standard Risk. The doctors expect the test result to show zero leukaemic cells in his bone marrow, as this first stage of treatment is designed to induce an immediate remission. As an aside, in the past 2 years, there was only 1 other case where the patient still had leukaemic cells on day 33.